Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Financing
Karius raises $100M in series C funding
By
LabPulse.com staff writers
Diagnostics firm Karius has secured $100 million in series C funding in a recent financing round.
May 6, 2024
Variantyx raises $36M in funding
By
LabPulse.com staff writers
Precision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.
April 30, 2024
Seaport Therapeutics launches with $100M financing round
By
LabPulse.com staff writers
Clinical-stage biopharmaceutical company Seaport Therapeutics launched with the announcement of the closing of a $100 million oversubscribed series A financing round.
April 9, 2024
Binx Health closes $65M financing round
By
LabPulse.com staff writers
Binx Health announced that it successfully closed a $65 million series F financing round.
April 5, 2024
Biofidelity completes $24M financing round
By
LabPulse.com staff writers
Genomics company Biofidelity announced that it has completed a financing round totaling $24 million, bringing the firm’s total funding since its founding in 2019 to $60 million.
April 3, 2024
Protein design firm Profluent raises $35M in funding
By
LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
Bluebird Bio secures up to $175M in debt financing
By
LabPulse.com staff writers
Bluebird Bio has secured up to $175 million in debt financing with Hercules Capital, having entered into a five-year term loan facility that provides funds in separate tranches.
March 18, 2024
Zephyr AI closes $111M series A funding round
By
LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
Eisai invests $15M in C2N to increase Alzheimer's test access
By
LabPulse.com staff writers
C2N Diagnostics has announced that pharmaceutical company Eisai has agreed to invest up to $15 million in C2N to provide broader access to Alzheimer’s disease tests.
March 6, 2024
Alamar Biosciences raises $100M in series C financing round
By
LabPulse.com staff writers
Precision proteomics company Alamar Biosciences has raised $100 million in an oversubscribed series C financing round, with a second close of an additional $28 million anticipated within the next 30 days.
February 27, 2024
Freenome raises $254M in funding to advance cancer test pipeline
By
LabPulse.com staff writers
Biotech firm Freenome has raised $254 million in new funding from new and existing investors to accelerate its pipeline of early detection cancer tests for its multiomics platform.
February 15, 2024
Accent Therapeutics raises $75M in series C funding round
By
LabPulse.com staff writers
Biopharmaceutical company Accent Therapeutics has raised $75 million in a series C financing round, with the aim of using the funds to advance two of its precision oncology candidates to clinical trials.
January 23, 2024
Page 1 of 8
Next Page